Jennifer Palacios

Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable interpretation of study results.  When analyzing percentages in multicenter trials, key considerations include which confidence interval method to use and whether, and how, to account for differences between centers. For a 95% confidence interval, coverage should be approximately 95%, while […]

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs in clinical development. However, regulatory expectations vary across regions and continue to evolve.  This webinar brings together three regional perspectives on the current regulatory landscape: the FDA’s draft guidance on Bayesian statistics, China’s CDE guidance on Bayesian approaches, and Bayesian-relevant expectations […]

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Regulatory-Grade External Controls In our final session, we’ll explore how AI is revolutionizing clinical trials through predictive modeling and the use of synthetic and simulated patients. We’ll discuss digital twins, virtual cohort simulations, and how to integrate real-world evidence (RWE) into trial […]

Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many organizations still have limited experience applying them, particularly when engaging with regulators. With multiple global agencies releasing further guidance in this area, it is useful to understand the current landscape of this trial area. In this webinar, we […]

Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s role in automating critical tasks in drug development. We will showcase how AI-powered technologies have been used to automate programming QC, systematic literature reviews, and streamline the identification of trial centers and KOLs, while highlighting AI’s role across clinical workflows […]

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and real-world settings. In this webinar, we will explore how combining predictive disease and care modeling with real-world data (RWD) can help translate efficacy observed in clinical trials into real-world effectiveness.  Using practical examples from rare disease settings, […]

About This Webinar In this session, we explore real-world use cases where AI and LLMs (Large Language Models) have been applied to explore large data sources such as omics, literature, and real-world data (RWD). We explore how AI can help identify optimal target populations, endpoints, and even support drug repurposing. Speaker: Billy Amzal, Ph.D.Head of […]

About This Webinar As expectations for robust, real-world evidence continue to grow, understanding how regulators evaluate causal analyses is becoming increasingly important. In this session, we will explore why causality matters, how agencies such as the FDA, EMA, and NICE are viewing causal inference, and what this means for study design and regulatory submissions. Speakers […]

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care through causal and federated learning, targeted maximum likelihood estimation (TMLE) and doubly robust methods.   Speakers: Ryan Batten, Senior Statistician, Phastar Julie Joss, Senior Researcher, Inria Josh Enxing, Senior Programmer, Phastar- Moderator Learning Points: Distinguishing correlation from causation in the […]

Phastar is sponsoring BBSW 2026, 5-6 November in Foster City, CA. Connect below to set-up a meeting or stop by Booth #2 to engage with our team. Schedule a meeting with us below:

Phastar is excited to be attending European Statistical Forum, 12 – 13 November in NH Budapest City, Budapest. Connect with us at our presentation or request a meeting below: Experiences of Utilizing the BOIN12 Method for Designing Rare/Small Population Oncology TrialsGiles Partington, Consultant Statistician13 November 2026 Schedule a time to meet below:

Phastar is excited to be attending PHUSE EU Connect, 15 – 18 November in Glasgow, Scotland Connect with us below or visit us at booth #31, our poster or one of our presentations to learn more about our solutions. Poster: The Mouse Behind the KeyboardChoe Floodgate, Senior Programmer I17 November, 17:30 GMT, Hall 2 | […]

Phastar is exhibiting at the PSI Medical Statistics Careers Event at, 18 November Cutler’s Hall in Sheffield. Connect below to set-up a meeting or stop by our table to connect with our team. Schedule a meeting with us below:

Phastar is delighted to be exhibiting at PHUSE APAC Connect 2027, 28-30 January in Bengaluru, India. Visit the Phastar team at our exhibit or visit our posters and presentations to find out more about our solutions. Schedule a time to meet below:

Phastar is sponsoring SCOPE Summit 2027, 1-4 March in Orlando, FL Connect below to set-up a meeting or stop by Booth #427 to engage with our team. Schedule a meeting with us below: